International Alport Syndrome Meeting Report Published

KFOC, Pedersen Family and Partners award two new 2014 Alport Syndrome Research Grants

Dr. Adeera Levin Awarded Kidney Foundation of Canada’s 2014 Medal for Research Excellence

First Nations Adults with Diabetes Have More than Double the Risk of End-Stage Kidney Disease

Dr. Marcello Tonelli Awarded 2013 Medal for Research Excellence for Changing Nephrology Practice in Canada and Beyond

Paying Living Kidney Donors May Be Cost-Effective and Help Prolong Lives

The Kidney Foundation congratulates Dr. Andreas Laupacis on being awarded the inaugural CIHR Barer-Flood Prize in Health Services and Policy Research

New Research to Discover a Cure for Rare Kidney Disease

CSN Announces Editor in Chief of New Journal

Dr. Adeera Levin appointed President of the International Society of Nephrology

Sugary Drinks May Increase Risk of Kidney Stones

Launch of new Canadian National Transplant Research Program

Alberta Researchers Receive Top Achievement in Health Research Award

Kidney Foundation of Canada Helps Fund World’s First Gene Therapy Clinical Trial for Fabry Disease

First-of-Its-Kind Canadian Project to Chart the Future of Dialysis Research

Lead Investigator on Landmark Walkerton Health Study Awarded 2012 Medal for Research Excellence

New Drug Shows Hope for ADPKD Treatment

New Findings Debunk Long-Held Theory that Kidney Disease is Part of the Normal Aging Process

The Kidney Foundation of Canada partners with Kidney Cancer Canada and Government to support national research network

Fri, 25 Oct 2013

Paying Living Kidney Donors May Be Cost-Effective and Help Prolong Lives

October 25, 2013 - A strategy of paying living kidney donors, with a consequent increase in the number of transplants performed, could be less costly and more effective than the current organ donation system, according to a new study co-authored by the University of Calgary’s Lianne Barnieh, PhD, and Dr. Braden Manns published in the Oct. 24 issue of Clinical Journal of the American Society of Nephrology.

According to their model, a strategy to increase the number of kidneys for transplantation by five per cent (a very conservative estimate) by paying living donors $10,000 could result in an incremental cost savings and a gain of quality-adjusted life years over a patient’s lifetime.

“Such a program could be cost saving because of the extra number of kidney transplants and, consequently, lower dialysis costs. Further, by increasing the number of people receiving a kidney transplant, this program could improve net health by increasing the quality and quantity of life for patients with end-stage renal disease,” says Barnieh.

The prevalence of End-Stage Renal Disease is increasing worldwide but transplantation rates have not kept pace. New strategies are urgently needed but there are considerable legal, ethical and moral issues surrounding the use of financial incentives in living kidney donation.

“While it is crucial that we increase kidney transplant rates in Canada, the commercial trade of human organs is illegal in most countries, largely because the practice often exploits the most vulnerable” said Paul Shay, Executive Director of The Kidney Foundation of Canada, “but we should consider all options to improve the donation rates”.

More than 80 international professional societies and governmental agencies, including The Kidney Foundation of Canada, have endorsed The Declaration of Istanbul, a policy document designed to promote both deceased and living donor transplantation around the world in a manner that protects the health and welfare of both recipients and donors while ending exploitation.

For more information:

The Kidney Foundation of Canada position statement on the commercial trade of human organs:

University of Calgary press release:

Abstract and full text versions of the study on the Clinical Journal of the American Society of Nephrology website:

Interview with Lianne Barnieh, PhD: